drugset / Trial / NCT01810549

Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study

NCT01810549

Phase 1 Completed 20 enrolled University of Zurich
RandomizedCrossoverDouble-blind

Summary

The aim of the study is to investigate, if postprandial fatigue symptoms after ingestion of a high-fat, high-carbohydrate meal are regulated by Interleukin (IL)-1 and can be prevented by inhibition of IL-1 using a single dose injection of a specific IL-1 receptor antagonist.

Timeline

Start
2013-03
Primary completion
2013-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Anakinra Protein / enzyme biologic 100 mg Subcutaneous

Indications

No indication recorded.